News and Announcements
OncoSil Appoints Michael Warrener as Global Sales and Marketing Director
- Published May 18, 2016 10:45AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
18th May 2016, ASX Announcement
OncoSil Medical Limited (ASX: OSL) (OncoSil Medical or the Company) is pleased to announce the appointment of Mr Michael Warrener as Global Sales and Marketing Director. Mr Warrener will be responsible for implementing the Company’s commercialisation strategy and infrastructure.
Mr Warrener will be based in Sydney and will oversee the initial market launch in Europe, Australia and key Asian markets. Mr Warrener will commence his role on 1st of June and his appointment completes the Senior Leadership Team of the Company.
Mr Warrener has forged a highly successful career in the pharmaceutical and medical device sector over a period of more than 23 years, including eight years with Sirtex Medical Ltd (ASX: SRX). During his time with Sirtex he held a number of senior management roles including Sales and Marketing Director for Europe and Middle East where he helped introduce then drive adoption of the Sir-Spheres product in the Australian, European Union and Middle East markets.
To view the full announcement, please click on the button below.